<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39409046</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>19</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 Vaccine Improved Hemostasis of a Patient with Protein S Deficiency: A Case Report.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">10717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms251910717</ELocationID><Abstract><AbstractText>A 16-year-old patient, while an infant, incurred right-sided hemiparesis and had difficulty breast feeding. She was later diagnosed with a neonatal stroke and her genetic testing showed a missense mutation in her <i>PROS1</i> (Protein S) gene. Both her grandfather and father, but not her mother, had hereditary Protein S (PS) deficiency. The patient was not prescribed any mediation due to her young age but was frequently checked by her physician. The patient's plasma was first collected at the age of 13, and the isolated plasma from the patient and her father were analyzed by aPTT, thrombin generation, and enzyme-linked immunosorbent assays. These analyses showed low PS activity and clotting time associated with the missense mutation in the <i>PROS1</i> gene. During the COVID-19 pandemic, the patient received her first Pfizer vaccination dose in 2021, followed by a booster dose in 2022. The plasma samples were collected 8 weeks post-immunization, after which her clotting parameters had improved for up to 6 months following vaccination. The patient's plasma showed a significant reduction in thrombin generation and an improved aPTT clotting time. Mass spectrometry analysis revealed that her antithrombin-III level was significantly higher post-vaccination, and both thrombin and FXII levels were significantly lowered compared with her father. To our knowledge, this is the first report to document that COVID-19 vaccination can lower the risk of thrombosis in a patient with inherited thrombophilia. Although the effect was observed on a single mutation, it would be interesting to investigate the effect of COVID-19 vaccinations on other thrombophilia.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mohammad</LastName><ForeName>Mohammad A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0009-0005-4199-8385</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malik</LastName><ForeName>Alaa</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0004-0875-8438</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thangada</LastName><ForeName>Lekha</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polanía-Villanueva</LastName><ForeName>Diana</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-7846-2948</Identifier><AffiliationInfo><Affiliation>Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zabaleta</LastName><ForeName>Jovanny</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-5961-6761</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majumder</LastName><ForeName>Rinku</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-1727-7220</Identifier><AffiliationInfo><Affiliation>Department of Interdisciplinary Oncology, Louisiana State University Health Sciences Center (LSUHSC), New Orleans, LA 70112, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C523390">PROS1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017293">Protein S</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006487" MajorTopicYN="N">Hemostasis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017293" MajorTopicYN="N">Protein S</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018455" MajorTopicYN="Y">Protein S Deficiency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013927" MajorTopicYN="N">Thrombosis</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">COVID-19 vaccination</Keyword><Keyword MajorTopicYN="N">Pfizer vaccine</Keyword><Keyword MajorTopicYN="N">protein S</Keyword><Keyword MajorTopicYN="N">protein S deficiency</Keyword><Keyword MajorTopicYN="N">thrombosis</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39409046</ArticleId><ArticleId IdType="pmc">PMC11477061</ArticleId><ArticleId IdType="doi">10.3390/ijms251910717</ArticleId><ArticleId IdType="pii">ijms251910717</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lane D.A., Philippou H., Huntington J.A. Directing thrombin. Blood. 2005;106:2605–2612. doi: 10.1182/blood-2005-04-1710.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2005-04-1710</ArticleId><ArticleId IdType="pubmed">15994286</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez V., Warad D. Pediatric Coagulation Disorders. Pediatr. Rev. 2016;37:279–291. doi: 10.1542/pir.2015-0062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/pir.2015-0062</ArticleId><ArticleId IdType="pubmed">27368359</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker F.J. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J. Biol. Chem. 1981;256:11128–11131. doi: 10.1016/S0021-9258(19)68566-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(19)68566-2</ArticleId><ArticleId IdType="pubmed">6457049</ArticleId></ArticleIdList></Reference><Reference><Citation>Hackeng T.M., Sere K.M., Tans G., Rosing J. Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proc. Natl. Acad. Sci. USA. 2006;103:3106–3111. doi: 10.1073/pnas.0504240103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0504240103</ArticleId><ArticleId IdType="pmc">PMC1413864</ArticleId><ArticleId IdType="pubmed">16488980</ArticleId></ArticleIdList></Reference><Reference><Citation>Chattopadhyay R., Sengupta T., Majumder R. Inhibition of intrinsic Xase by protein S: A novel regulatory role of protein S independent of activated protein C. Arterioscler. Thromb. Vasc. Biol. 2012;32:2387–2393. doi: 10.1161/ATVBAHA.112.250928.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.112.250928</ArticleId><ArticleId IdType="pubmed">22904276</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstyn-Cohen T., Heeb M.J., Lemke G. Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis. J. Clin. Investig. 2009;119:2942–2953. doi: 10.1172/JCI39325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI39325</ArticleId><ArticleId IdType="pmc">PMC2752078</ArticleId><ArticleId IdType="pubmed">19729839</ArticleId></ArticleIdList></Reference><Reference><Citation>Majumder R., Nguyen T. Protein S: Function, regulation, and clinical perspectives. Curr. Opin. Hematol. 2021;28:339–344. doi: 10.1097/MOH.0000000000000663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000663</ArticleId><ArticleId IdType="pmc">PMC8373800</ArticleId><ArticleId IdType="pubmed">34224431</ArticleId></ArticleIdList></Reference><Reference><Citation>Sim M.M.S., Wood J.P. Dysregulation of Protein S in COVID-19. Best. Pract. Res. Clin. Haematol. 2022;35:101376. doi: 10.1016/j.beha.2022.101376.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2022.101376</ArticleId><ArticleId IdType="pmc">PMC9395234</ArticleId><ArticleId IdType="pubmed">36494145</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari E., Sartre B., Squara F., Contenti J., Occelli C., Lemoel F., Levraut J., Doyen D., Dellamonica J., Mondain V., et al. High Prevalence of Acquired Thrombophilia without Prognosis Value in Patients with Coronavirus Disease 2019. J. Am. Heart Assoc. 2020;9:e017773. doi: 10.1161/JAHA.120.017773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017773</ArticleId><ArticleId IdType="pmc">PMC7763401</ArticleId><ArticleId IdType="pubmed">32972320</ArticleId></ArticleIdList></Reference><Reference><Citation>Cines D.B., Bussel J.B. SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia. N. Engl. J. Med. 2021;384:2254–2256. doi: 10.1056/NEJMe2106315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMe2106315</ArticleId><ArticleId IdType="pmc">PMC8063912</ArticleId><ArticleId IdType="pubmed">33861524</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Mesa J.E., Galindo-Coral S., Montes M.C., Munoz Martin A.J. Thrombosis and Coagulopathy in COVID-19. Curr. Probl. Cardiol. 2021;46:100742. doi: 10.1016/j.cpcardiol.2020.100742.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpcardiol.2020.100742</ArticleId><ArticleId IdType="pmc">PMC7605852</ArticleId><ArticleId IdType="pubmed">33243440</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim E.J., Yoo S.J. Pulmonary Embolism after Vaccination with the COVID-19 Vaccine (Pfizer, BNT162b2): A Case Report. Vaccines. 2023;11:1075. doi: 10.3390/vaccines11061075.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11061075</ArticleId><ArticleId IdType="pmc">PMC10303489</ArticleId><ArticleId IdType="pubmed">37376463</ArticleId></ArticleIdList></Reference><Reference><Citation>Formstone C.J., Wacey A.I., Berg L.P., Rahman S., Bevan D., Rowley M., Voke J., Bernardi F., Legnani C., Simioni P., et al. Detection and characterization of seven novel protein S (PROS) gene lesions: Evaluation of reverse transcript-polymerase chain reaction as a mutation screening strategy. Blood. 1995;86:2632–2641. doi: 10.1182/blood.V86.7.2632.2632.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V86.7.2632.2632</ArticleId><ArticleId IdType="pubmed">7545463</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Tun A.M., Gupta K., Tuma F. StatPearls. StatPearls; Treasure Island, FL, USA: 2024. Protein S Deficiency.</Citation></Reference><Reference><Citation>Pegelow C.H., Ledford M., Young J.N., Zilleruelo G. Severe protein S deficiency in a newborn. Pediatrics. 1992;89:674–676. doi: 10.1542/peds.89.4.674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.89.4.674</ArticleId><ArticleId IdType="pubmed">1532635</ArticleId></ArticleIdList></Reference><Reference><Citation>Dogan Y., Aygun D., Yilmaz Y., Kanra G., Secmeer G., Besbas N., Gurgey A. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans. Pediatr. Hematol. Oncol. 2003;20:1–5. doi: 10.1080/0880010390158478.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0880010390158478</ArticleId><ArticleId IdType="pubmed">12687747</ArticleId></ArticleIdList></Reference><Reference><Citation>Gandrille S., Borgel D., Sala N., Espinosa-Parrilla Y., Simmonds R., Rezende S., Lind B., Mannhalter C., Pabinger I., Reitsma P.H., et al. Protein S deficiency: A database of mutations--summary of the first update. Thromb. Haemost. 2000;84:918.</Citation><ArticleIdList><ArticleId IdType="pubmed">11127877</ArticleId></ArticleIdList></Reference><Reference><Citation>Juhl D., Kuta P., Shneyder M., Wunsche F., Nowak-Gottl U. Two Novel Variants in the Protein S Gene PROS1 Are Associated with Protein S Deficiency and Thrombophilia. Acta Haematol. 2021;144:222–226. doi: 10.1159/000508525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000508525</ArticleId><ArticleId IdType="pubmed">32653888</ArticleId></ArticleIdList></Reference><Reference><Citation>Mele F., Tafuri S., Stefanizzi P., Amati D.A., Calvano M., Leonardelli M., Macorano E., Duma S., De Gabriele G., Introna F., et al. Cerebral venous sinus thrombosis after COVID-19 vaccination and congenital deficiency of coagulation factors: Is there a correlation? Hum. Vaccin. Immunother. 2022;18:2095166. doi: 10.1080/21645515.2022.2095166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21645515.2022.2095166</ArticleId><ArticleId IdType="pmc">PMC9746424</ArticleId><ArticleId IdType="pubmed">35895937</ArticleId></ArticleIdList></Reference><Reference><Citation>Chirumamilla Y., Almerstani Y., Marcus H., Bachuwa G. Protein S Deficiency and COVID-19: A Brutal Combination Leading to Acute Submassive Bilateral Pulmonary Embolism. Cureus. 2023;15:e41560. doi: 10.7759/cureus.41560.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.41560</ArticleId><ArticleId IdType="pmc">PMC10405865</ArticleId><ArticleId IdType="pubmed">37554606</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekal S., Husari G., Okura M., Huang C.A., Bukari M.S. Thrombosis Development After mRNA COVID-19 Vaccine Administration: A Case Series. Cureus. 2023;15:e41371. doi: 10.7759/cureus.41371.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.41371</ArticleId><ArticleId IdType="pmc">PMC10400017</ArticleId><ArticleId IdType="pubmed">37546104</ArticleId></ArticleIdList></Reference><Reference><Citation>Miri C., Bouchlarhem A., Boulouiz S., El Ouafi N., Bazid Z. Pulmonary embolism with junctional tachycardia: A serious complication after COVID-19 vaccination. Ann. Med. Surg. 2022;80:103983. doi: 10.1016/j.amsu.2022.103983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amsu.2022.103983</ArticleId><ArticleId IdType="pmc">PMC9238028</ArticleId><ArticleId IdType="pubmed">35784614</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke G., Silverman G.J. Blood clots and TAM receptor signalling in COVID-19 pathogenesis. Nat. Rev. Immunol. 2020;20:395–396. doi: 10.1038/s41577-020-0354-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0354-x</ArticleId><ArticleId IdType="pmc">PMC7264968</ArticleId><ArticleId IdType="pubmed">32488201</ArticleId></ArticleIdList></Reference><Reference><Citation>Gjorgjieva T., Chaloemtoem A., Shahin T., Bayaraa O., Dieng M.M., Alshaikh M., Abdalbaqi M., Del Monte J., Begum G., Leonor C., et al. Systems genetics identifies miRNA-mediated regulation of host response in COVID-19. Hum. Genom. 2023;17:49. doi: 10.1186/s40246-023-00494-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40246-023-00494-4</ArticleId><ArticleId IdType="pmc">PMC10257974</ArticleId><ArticleId IdType="pubmed">37303042</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W.C., Hu S.Y., Shen C.F., Cheng M.H., Hong J.J., Shen C.J., Cheng C.M. COVID-19 Vaccination in Pregnancy: Pilot Study for Maternal and Neonatal MicroRNA Profiles. Vaccines. 2023;11:1814. doi: 10.3390/vaccines11121814.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11121814</ArticleId><ArticleId IdType="pmc">PMC10747030</ArticleId><ArticleId IdType="pubmed">38140218</ArticleId></ArticleIdList></Reference><Reference><Citation>Talotta R. COVID-19 mRNA vaccines as hypothetical epigenetic players: Results from an in silico analysis, considerations and perspectives. Vaccine. 2023;41:5182–5194. doi: 10.1016/j.vaccine.2023.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2023.07.007</ArticleId><ArticleId IdType="pubmed">37453842</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed R.H., Abdulrahman Z.F.A., Mohammad D.K. The impact of COVID-19 on microRNA and CD marker expression in AML patients. Sci. Rep. 2024;14:14251. doi: 10.1038/s41598-024-64775-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-64775-1</ArticleId><ArticleId IdType="pmc">PMC11190249</ArticleId><ArticleId IdType="pubmed">38902412</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilyazova I., Timasheva Y., Karunas A., Kazantseva A., Sufianov A., Mashkin A., Korytina G., Wang Y., Gareev I., Khusnutdinova E. COVID-19: Mechanisms, risk factors, genetics, non-coding RNAs and neurologic impairments. Noncoding RNA Res. 2023;8:240–254. doi: 10.1016/j.ncrna.2023.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2023.02.007</ArticleId><ArticleId IdType="pmc">PMC9946734</ArticleId><ArticleId IdType="pubmed">36852336</ArticleId></ArticleIdList></Reference><Reference><Citation>Roustai Geraylow K., Hemmati R., Kadkhoda S., Ghafouri-Fard S. miRNA expression in COVID-19. Gene Rep. 2022;28:101641. doi: 10.1016/j.genrep.2022.101641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2022.101641</ArticleId><ArticleId IdType="pmc">PMC9288248</ArticleId><ArticleId IdType="pubmed">35875722</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay J.W., Romeo G., Hughes Q.W., Baker R.I. Micro-ribonucleic Acid 494 regulation of protein S expression. J. Thromb. Haemost. 2013;11:1547–1555. doi: 10.1111/jth.12331.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jth.12331</ArticleId><ArticleId IdType="pubmed">23789915</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasizadeh R., Aghbash P.S., Nahand J.S., Entezari-Maleki T., Baghi H.B. SARS-CoV-2-associated organs failure and inflammation: A focus on the role of cellular and viral microRNAs. Virol. J. 2023;20:179. doi: 10.1186/s12985-023-02152-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02152-6</ArticleId><ArticleId IdType="pmc">PMC10413769</ArticleId><ArticleId IdType="pubmed">37559103</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Rius A., Lopez S., Martinez-Perez A., Souto J.C., Soria J.M. Identification of a Plasma MicroRNA Profile Associated With Venous Thrombosis. Arterioscler. Thromb. Vasc. Biol. 2020;40:1392–1399. doi: 10.1161/ATVBAHA.120.314092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/ATVBAHA.120.314092</ArticleId><ArticleId IdType="pubmed">32160777</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoichitoiu L.E., Pinte L., Balea M.I., Nedelcu V., Badea C., Baicus C. Anticoagulant protein S in COVID-19: Low activity, and associated with outcome. Rom. J. Intern. Med. 2020;58:251–258. doi: 10.2478/rjim-2020-0024.</Citation><ArticleIdList><ArticleId IdType="doi">10.2478/rjim-2020-0024</ArticleId><ArticleId IdType="pubmed">32841167</ArticleId></ArticleIdList></Reference><Reference><Citation>Moatar A.I., Chis A.R., Romanescu M., Ciordas P.D., Nitusca D., Marian C., Oancea C., Sirbu I.O. Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients. Sci. Rep. 2023;13:13806. doi: 10.1038/s41598-023-40754-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-40754-w</ArticleId><ArticleId IdType="pmc">PMC10447562</ArticleId><ArticleId IdType="pubmed">37612439</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan A., Arefanian H., Channanath A.M., AlKhairi I., Cherian P., Devarajan S., Thanaraj T.A., Abu-Farha M., Abubaker J., Al-Mulla F. Association of COVID-19 Vaccines ChAdOx1-S and BNT162b2 with Circulating Levels of Coagulation Factors and Antithrombin. Vaccines. 2022;10:1226. doi: 10.3390/vaccines10081226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10081226</ArticleId><ArticleId IdType="pmc">PMC9415160</ArticleId><ArticleId IdType="pubmed">36016114</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>